Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-034777
Filing Date
2019-06-05
Accepted
2019-06-05 16:52:36
Documents
1
Period of Report
2019-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3884
  Complete submission text file 0001209191-19-034777.txt   5240
Mailing Address UCLA SCHOOL OF MEDICINE 10833 LE CONTE 66-118 CHS BOX 951738 LOS ANGELES CA 9095-1738
Business Address
Belldegrun Arie (Reporting) CIK: 0001296549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 19880398

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations